Bausch Health Companies Inc. (BHCN)
BMV
Closed
Oct 9, 2026
Day's Range
96.0052 wk Range
83.00Overview - BHCN - Bausch Health Companies Inc.
Key Statistics
Valuation
Enterprise Value
1.00T
P/E (Trailing)
‪11.75‬
PEG Ratio
‪0.16‬
Price / Sales (TTM)
‪3.30‬
Price / Book
‪-44.88‬
EV / EBITDA
‪14.28‬
Profitability
Gross Margin
‪72.93%‬
Profit Margin
‪-10.11%‬
Operating Margin
‪27.17%‬
Return on Assets
‪6.56%‬
Return on Equity
‪41.64%‬
Ownership
Shares Outstanding
373.90M
Float
260.57M
Held by Insiders
‪11.11%‬
Held by Institutions
‪65.07%‬
Price stats
Beta
‪0.37‬
50-Day Avg
‪96.96‬
200-Day Avg
‪114.81‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BHCN - Bausch Health Companies Inc.
Peers - BHCN - Bausch Health Companies Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BMV.
Profile Summary - BHCN - Bausch Health Companies Inc.
About
Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company focused on developing, manufacturing, and marketing healthcare products across multiple therapeutic areas. Bausch Health serves the gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
